產(chǎn)品詳情
僅用于工業(yè)應(yīng)用或科學(xué)研究,不可用于人類或動(dòng)物的臨床診斷或治療,非藥用. Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance